Your browser doesn't support javascript.
loading
Paradigm shift of drug information centers during the COVID-19 pandemic.
Khatiwada, Asmita Priyadarshini; Shakya, Sujyoti; Shrestha, Sunil.
Afiliação
  • Khatiwada AP; Department of Pharmaceutical and Health Service Research, Nepal Health Research and Innovation Foundation, Lalitpur, Nepal.
  • Shakya S; Department of Pharmaceutical and Health Service Research, Nepal Health Research and Innovation Foundation, Lalitpur, Nepal.
  • Shrestha S; Department of Pharmacy, Nobel College, Kathmandu, Nepal.
Drugs Ther Perspect ; 36(9): 389-395, 2020.
Article em En | MEDLINE | ID: mdl-32837192
ABSTRACT
The novel coronavirus disease 2019 (COVID-19) pandemic is a major global threat affecting millions of lives throughout the world physically and psychologically. With the asymptomatic presentation of COVID-19 in many patients and the similarity of its symptoms with the common cold and influenza, the need for accurate information on the disease is very important for its identification and proper management. Accurate information on the disease, its prevention and treatment can be disseminated through drug information centers (DICs). DICs are usually staffed by pharmacists and/or clinical pharmacists/pharmacologists. DICs are a reliable source of current and unbiased information on COVID-19 and its associated complications, including management options for healthcare professionals and the public. In addition to health and drug information, pharmacists working in the DICs can be involved in the management of the patients' health by providing information on home care and safety, medication management of patients with chronic comorbid illnesses, and psychological advice. This article explores the possible additional roles DICs can play, besides providing drug information within the hospital or in the community.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Drugs Ther Perspect Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Nepal

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Drugs Ther Perspect Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Nepal